Published online 18 September 2000.
© The Rockefeller University Press, 0022-1007/2000/9/857/ $5.00
The Journal of Experimental Medicine, Volume 192, Number 6, September 18, 2000 857-870
Nitric Oxide–Dependent Activation of P53 Suppresses Bleomycin-Induced Apoptosis in the Lung
Darren W. Davisa,b,
Douglas A. Weidnerc,
Andrij Holiana,d, and
David J. McConkeya,b
a Program in Toxicology, University of Texas-Houston Graduate School of Biomedical Sciences, Houston, Texas 77030
b Department of Cancer Biology, University of Texas-MD Anderson Cancer Center, Houston, Texas 77030
c Department of Molecular Hematology and Therapy, University of Texas-MD Anderson Cancer Center, Houston, Texas 77030
d Department of Pulmonary and Critical Care Medicine, University of Texas Medical School, Houston, Texas 77030
Department of Cancer Biology-173, U.T. M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.713-792-8747713-792-8591
Chronic inflammation leading to pulmonary fibrosis develops in response to environmental pollutants, radiotherapy, or certain cancer chemotherapeutic agents. We speculated that lung injury might be mediated by p53, a proapoptotic transcription factor widely implicated in the response of cells to DNA damage. Intratracheal administration of bleomycin led to caspase-mediated DNA fragmentation characteristic of apoptosis. The effects of bleomycin were associated with translocation of p53 from the cytosol to the nucleus only in alveolar macrophages that had been exposed to the drug in vivo, suggesting that the lung microenvironment regulated p53 activation. Experiments with a thiol antioxidant (N-acetylcysteine) in vivo and nitric oxide (NO) donors in vitro confirmed that reactive oxygen species were required for p53 activation. A specific role for NO was demonstrated in experiments with inducible nitric oxide synthase (iNOS)–/– macrophages, which failed to demonstrate nuclear p53 localization after in vivo bleomycin exposure. Strikingly, rates of bleomycin-induced apoptosis were at least twofold higher in p53–/– C57BL/6 mice compared with heterozygous or wild-type littermates. Similarly, levels of apoptosis were also twofold higher in the lungs of iNOS–/– mice than were observed in wild-type controls. Consistent with a role for apoptosis in chronic lung injury, levels of bleomycin-induced inflammation were substantially higher in iNOS–/– and p53–/– mice compared with wild-type controls. Together, our results demonstrate that iNOS and p53 mediate a novel apoptosis-suppressing pathway in the lung.
Key Words: NOS-2 TUNEL macrophage oxygen radical inflammation
Abbreviations used in this paper: iNOS, inducible nitric oxide synthase; LSC, laser scanning cytometer; NAC, N-acetylcysteine; PI, propidium iodide; SNAP, s-nitrosoaminopereillamine; TUNEL, TdT-uridine nick end labeling.
© 2000 The Rockefeller University Press

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Tourneux, P., Markham, N., Seedorf, G., Balasubramaniam, V., Abman, S. H.
(2009). Inhaled nitric oxide improves lung structure and pulmonary hypertension in a model of bleomycin-induced bronchopulmonary dysplasia in neonatal rats. Am. J. Physiol. Lung Cell. Mol. Physiol.
297: L1103-L1111
[Abstract]
[Full Text]
-
Drakopanagiotakis, F., Xifteri, A., Polychronopoulos, V., Bouros, D.
(2008). Apoptosis in lung injury and fibrosis. Eur Respir J
32: 1631-1638
[Abstract]
[Full Text]
-
Carreras, M. C., Poderoso, J. J.
(2007). Mitochondrial nitric oxide in the signaling of cell integrated responses. Am. J. Physiol. Cell Physiol.
292: C1569-C1580
[Abstract]
[Full Text]
-
Mannick, J. B.
(2006). Immunoregulatory and antimicrobial effects of nitrogen oxides.. Proc Am Thorac Soc
3: 161-165
[Abstract]
[Full Text]
-
Nawrocki, S. T., Carew, J. S., Pino, M. S., Highshaw, R. A., Dunner, K. Jr., Huang, P., Abbruzzese, J. L., McConkey, D. J.
(2005). Bortezomib Sensitizes Pancreatic Cancer Cells to Endoplasmic Reticulum Stress-Mediated Apoptosis. Cancer Res.
65: 11658-11666
[Abstract]
[Full Text]
-
Zhang, J., Jin, B., Li, L., Block, E. R., Patel, J. M.
(2005). Nitric oxide-induced persistent inhibition and nitrosylation of active site cysteine residues of mitochondrial cytochrome-c oxidase in lung endothelial cells. Am. J. Physiol. Cell Physiol.
288: C840-C849
[Abstract]
[Full Text]
-
Davis, D. W., Inoue, K., Dinney, C. P. N., Hicklin, D. J., Abbruzzese, J. L., McConkey, D. J.
(2004). Regional Effects of an Antivascular Endothelial Growth Factor Receptor Monoclonal Antibody on Receptor Phosphorylation and Apoptosis in Human 253J B-V Bladder Cancer Xenografts. Cancer Res.
64: 4601-4610
[Abstract]
[Full Text]
-
Kamat, A. M., Karashima, T., Davis, D. W., Lashinger, L., Bar-Eli, M., Millikan, R., Shen, Y., Dinney, C. P. N., McConkey, D. J.
(2004). The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo. Molecular Cancer Therapeutics
3: 279-290
[Abstract]
[Full Text]
-
Nawrocki, S. T., Sweeney-Gotsch, B., Takamori, R., McConkey, D. J.
(2004). The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts. Molecular Cancer Therapeutics
3: 59-70
[Abstract]
[Full Text]
-
Davis, D. W., Shen, Y., Mullani, N. A., Wen, S., Herbst, R. S., O'Reilly, M., Abbruzzese, J. L., McConkey, D. J.
(2004). Quantitative Analysis of Biomarkers Defines an Optimal Biological Dose for Recombinant Human Endostatin in Primary Human Tumors. Clin. Cancer Res.
10: 33-42
[Abstract]
[Full Text]
-
Chung, M. P., Monick, M. M., Hamzeh, N. Y., Butler, N. S., Powers, L. S., Hunninghake, G. W.
(2003). Role of Repeated Lung Injury and Genetic Background in Bleomycin-Induced Fibrosis. Am. J. Respir. Cell Mol. Bio.
29: 375-380
[Abstract]
[Full Text]
-
Davis, D. W., Buchholz, T. A., Hess, K. R., Sahin, A. A., Valero, V., McConkey, D. J.
(2003). Automated Quantification of Apoptosis after Neoadjuvant Chemotherapy for Breast Cancer: Early Assessment Predicts Clinical Response. Clin. Cancer Res.
9: 955-960
[Abstract]
[Full Text]
-
Nawrocki, S. T., Bruns, C. J., Harbison, M. T., Bold, R. J., Gotsch, B. S., Abbruzzese, J. L., Elliott, P., Adams, J., McConkey, D. J.
(2002). Effects of the Proteasome Inhibitor PS-341 on Apoptosis and Angiogenesis in Orthotopic Human Pancreatic Tumor Xenografts. Molecular Cancer Therapeutics
1: 1243-1253
[Abstract]
[Full Text]
-
Ikeguchi, M., Ueta, T., Yamane, Y., Hirooka, Y., Kaibara, N.
(2002). Inducible Nitric Oxide Synthase and Survivin Messenger RNA Expression in Hepatocellular Carcinoma. Clin. Cancer Res.
8: 3131-3136
[Abstract]
[Full Text]
-
Ghosh, S., Mendoza, T., Ortiz, L. A., Hoyle, G. W., Fermin, C. D., Brody, A. R., Friedman, M., Morris, G. F.
(2002). Bleomycin Sensitivity of Mice Expressing Dominant-Negative p53 in the Lung Epithelium. Am. J. Respir. Crit. Care Med.
166: 890-897
[Abstract]
[Full Text]
-
Kim, S.-J., Hwang, S.-G., Shin, D. Y., Kang, S.-S., Chun, J.-S.
(2002). p38 Kinase Regulates Nitric Oxide-induced Apoptosis of Articular Chondrocytes by Accumulating p53 via NFkappa B-dependent Transcription and Stabilization by Serine 15 Phosphorylation. J. Biol. Chem.
277: 33501-33508
[Abstract]
[Full Text]